Navigation Links
MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
Date:11/12/2008

MOUNTAIN VIEW, Calif., Nov. 12 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced financial results for the third quarter ended September 30, 2008.

The net loss for the third quarter ended September 30, 2008 was $20.4 million compared with $9.8 million during the same period in 2007. The net loss for the nine months ended September 30, 2008 was $51.1 million compared to $25.2 million for the nine months ended September 30, 2007. As of September 30, 2008, MAP Pharmaceuticals had cash, cash equivalents and short-term investments of $63.0 million.

"We had a very busy and productive third quarter with two active Phase 3 clinical programs ongoing. We completed patient enrollment of our Phase 3 trial of Unit Dose Budesonide, or UDB, for the potential treatment of pediatric asthma, and continued enrollment of our Phase 3 trial of MAP0004 for the potential treatment of migraine," said Timothy S. Nelson, President and Chief Executive Officer of MAP Pharmaceuticals. "In this environment, we continue to manage our resources prudently as we advance toward our goal of commercializing clearly differentiated products that address major market opportunities."

Third Quarter 2008 and Recent Accomplishments

Clinical development

-- UDB: Completed enrollment and randomized approximately 360 patients in a Phase 3 clinical trial to evaluate UDB for the potential treatment of pediatric asthma. The last patient in this trial is expected to complete the 12-week treatment period by the end of 2008.

-- MAP0004: Initiated enrollment in a Phase 3 clinical trial to evaluate MAP0004 for the potential treatment of migraine, pursuant to a Special Protocol Assessment with the U.S. Food and Drug Admin
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
2. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
3. Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008
4. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
5. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
6. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
7. Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product
8. Memory Pharmaceuticals Announces Six Abstracts Accepted for Presentation at Society for Neuroscience Meeting
9. Alseres Pharmaceuticals, Inc. To Host Third Quarter 2008 Conference Call
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
11. Sagent Pharmaceuticals Announces Presentations at Upcoming Lazard Capital Markets and Piper Jaffray Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... ... is an unavoidable result of incision or injury to the skin. Unsightly as it may ... appearance of a scar is dependent on many factors – the size and depth of ... to near invisibility on their own over a period of months,” says Dr. Jocelyn ...
(Date:9/3/2015)... ... , ... “Love in Tokyo” an independent romantic comedy film by Michael Solton ... and will be released on DVD early next year, by Maverick Entertainment. The film ... and singer/songwriter, and Jason London, lead from “Dazed and Confused.” , “Love in ...
(Date:9/3/2015)... ... 2015 , ... Representatives with State Farm Agent EJ Roberts ... Gulf Babypalooza on September 19, 2015. , “We will be providing information to ... We will be discussing setting up college funds, offering information specific to their ...
(Date:9/3/2015)... ... September 03, 2015 , ... At Renew Man™, we have seen ... traditional health care model, where the primary care physician dictates and the patient obeys. ... become educated about their health issues and empowered to choose their own treatment options. ...
(Date:9/3/2015)... ... 03, 2015 , ... About 220,800 new cases of prostate cancer are reported each year, along ... with prostate cancer during their lifetime. While only one man in 10,000 will typically get ... age 65, according to the American Cancer Society. , Prostate cancer ...
Breaking Medicine News(10 mins):Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3
... Care Physician Recruitment, ORLANDO, Fla., Nov. 10 ... - with primary care,being especially hard hit. As the ... shortage promises to get worse with major,repercussions for the ... working to address this issue with a new policy ...
... - BELLUS Health Inc. (NASDAQ:,BLUS; TSX: BLU) reports ... For the three-month period ended September 30, 2008, ... compared to $13,889,000 ($0.29,per share) for the corresponding ... September 30, 2008, the net loss amounted to,$36,703,000 ...
... Adds Fuel to Double-Digit Growth in Europe, PROVO, ... (NYSE: NUS ) opened for business in the ... adds further fuel to the,company,s increasingly successful European region., ... the,Czech Republic is becoming a dynamic market for direct ...
... 10 Medipacs, Inc., a Tucson based,drug delivery ... and Agustin Vilches, RPh to the company,s medical ... and together have practiced,in Hospital, Hospice and Home ... years at Swedish Hospital Medical,Center and the Fred ...
... and Address Vital Breast Cancer Health ... Care Issues for All Illinois Residents, SPRINGFIELD, Ill., Nov. 10 ... of the global breast cancer movement,will convene at the first-ever Komen ... state,s breast health coverage, discuss,the impact of statewide breast health programs ...
... Nov. 10 Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) ... results on November 13, 2008, before the open,of U.S. ... and live audio webcast to discuss the results and ... Time/5:30 a.m. Pacific,Time., The live webcast and press ...
Cached Medicine News:Health News:AMA Works to Reverse Primary Care Physician Shortage 2Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 2Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 3Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 4Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 5Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 6Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 7Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 8Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 9Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 10Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 11Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 12Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 13Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 14Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 15Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 16Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 17Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 18Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 19Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 20Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 21Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 22Health News:BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update 23Health News:Nu Skin Enterprises Opens the Czech Republic 2Health News:Medipacs Appoints Advisory Board Members 2Health News:Susan G. Komen for the Cure(R) Hosts Inaugural Illinois State Summit in Springfield 2Health News:Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008 2
(Date:9/2/2015)... YORK , Sept. 2, 2015 ... by the collapse of one or more vertebral ... patients. Osteoporosis, a degenerative bone disease, is a ... bone disease, multiple myeloma, metastatic spinal tumors, and ... can undergo vertebroplasty and kyphoplasty to rectify the ...
(Date:9/2/2015)... Sept. 2, 2015  The report on breast cancer ... breast cancer drugs on the basis of the molecules ... from the inner lining of milk ducts or lobules ... type of tumor that can spread to other cells ... starts in lobules is referred as lobular carcinoma, while ...
(Date:9/2/2015)... -- About Neuroendovascular Coil A ... and ruptured brain aneurysm (a weakened area in ... as an endovascular coiling or endovascular embolization. During ... flow in an aneurysm. The endovascular coiling treatment ... interventional neuroradiologist using fluoroscopic imaging guidance. Neuroendovascular coils ...
Breaking Medicine Technology:Global Balloon Kyphoplasty Market 2015-2019 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Global Neuroendovascular Coil Market 2015-2019 2
... VIA Pharmaceuticals,Inc. (Nasdaq: VIAP ), a biotechnology ... treatment of cardiovascular disease, announced today that,it will ... results of the,VIA-2291 Phase 2 acute coronary syndrome ... American Heart Association (AHA) Scientific,Sessions 2008 on Sunday, ...
... Nov. 5 Medarex, Inc.,(Nasdaq: MEDX ) ... payment of,an undisclosed amount from its licensing partner, ... 2 trial of CNTO 95, a fully human ... tumor-induced,angiogenesis. The CNTO 95 human antibody was generated ...
Cached Medicine Technology:VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA 2Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors 2
... ergonomics, and value!, Comfortable feel ... non-slip, contoured handle , Finer control ... spring action , Completely autoclavable for ... need for recalibration , Easy-to-read precision ...
... the range from 2ul to 5000ul. Fills ... design prevents inadvertent volume change. Novel hand ... pipette is autoclavable at 121C(250F). To prevent ... Suitable for one-handed operation. Auto or Normal ...
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 0.5-10 microliter range....
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
Medicine Products: